Biological treatment in elderly and young patients with ankylosing spondylitis: TURKBIO real-life data results

Objectives: This study aims to investigate the effect of age on disease activity and biological treatment in patients with ankylosing spondylitis (AS). Patients and methods: A total of 811 AS patients registered in the TURKBIO registry database between 2011 and 2019 were categorized according to...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Sadettin Uslu, Nurullah Akkoç, Merih Birlik, İsmail Sarı, Özgül Soysal Gündüz, Sema Yılmaz, Servet Yolbaş, Aydan Köken Avşar, Ayşe Cefle, Nevsun İnanç, Servet Akar, Soner Şenel, Ediz Dalkılıç, Gerçek Şen, Özkan Urak, Semih Gülle, Fatoş Önen
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Turkish Society of Gastroenterology 2024-06-01
Rangatū:	The Turkish Journal of Gastroenterology
Ngā marau:	Adverse event ankylosing spondylitis biological disease-modifying anti-rheumatic drug geriatric tumor necrosis factor inhibitor.
Urunga tuihono:	http://avestema.com.dedi9374.your-server.de/index.php/pub/article/view/1411
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!